Multiple platforms limited their ability to manage consent
Gerard Akkerhuis, Senior Vice President Partner Management and special projects at Daiichi Sankyo Europe (DSE) recognised the importance of putting HCPs at the forefront of their strategic planning and was looking for solutions that would deliver additional value to their target audience. He also identified that delivering value to HCPs would present an opportunity to capture consent to share further scientific content and foster the right dialogue.
Having participated in a strategic customer brainstorming workshop on the recommendation of a partner, Tangent90’s capabilities to improve customer engagement were acknowledged and the ease of deployment with different systems suited DSE’s plans to transition to a new CRM. Tangent90’s Trustrack solution offered a comprehensive solution. It was agile enough to work as a standalone platform but could be quickly scaled to integrate with local and global systems. It could also manage both scientific and promotional content, allowing the user to clearly identify both and share accordingly.
Any solution would need to grow with the business requirements – ensuring easy management of content distribution as well as being flexible and scalable enough to be used either independently or integrated with the new CRM system planned.
Daiichi Sankyo are now able to easily capture consent and share digital content via a single platform
Akkerhuis explains that the solution was first piloted in Spain, using their local SEIKA CRM system. There are 79 reps in Spain using the Trustrack web app with consent capture and content sharing capabilities.
Working alongside the team in Spain, Tangent90 created demo videos prior to launch to help support the uptake and adherence of the solution. The approach was very hands-on to ensure a smooth roll-out and support the local teams. A particular benefit for the Spanish team was the ability to self-administer the platform for promotional content which allowed a level of local control.
Trustrack is the solution of choice for the end-to-end distribution of published scientific content within Veeva Systems CRM channels.
The implementation of Trustrack has proved so successful, that it has been rolled out to another rare disease business unit covering 15 offices worldwide.
Watch our webinar where experts from Tangent90, Novartis, GSK, Boehringer Ingelheim, Veeva, Executegy and formerly BionTech, will discuss how you can leverage the value HCPs place on scientific content.